BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 37895205)

  • 1. Decoding Cancer Evolution: Integrating Genetic and Non-Genetic Insights.
    Ashouri A; Zhang C; Gaiti F
    Genes (Basel); 2023 Sep; 14(10):. PubMed ID: 37895205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How the evolution of multicellularity set the stage for cancer.
    Trigos AS; Pearson RB; Papenfuss AT; Goode DL
    Br J Cancer; 2018 Jan; 118(2):145-152. PubMed ID: 29337961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The evolution of multicellularity and cancer: views and paradigms.
    Nedelcu AM
    Biochem Soc Trans; 2020 Aug; 48(4):1505-1518. PubMed ID: 32677677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and non-genetic clonal diversity in cancer evolution.
    Black JRM; McGranahan N
    Nat Rev Cancer; 2021 Jun; 21(6):379-392. PubMed ID: 33727690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intra-tumour heterogeneity - going beyond genetics.
    Caiado F; Silva-Santos B; Norell H
    FEBS J; 2016 Jun; 283(12):2245-58. PubMed ID: 26945550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The reverse evolution from multicellularity to unicellularity during carcinogenesis.
    Chen H; Lin F; Xing K; He X
    Nat Commun; 2015 Mar; 6():6367. PubMed ID: 25751731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intratumoural immune heterogeneity as a hallmark of tumour evolution and progression in hepatocellular carcinoma.
    Nguyen PHD; Ma S; Phua CZJ; Kaya NA; Lai HLH; Lim CJ; Lim JQ; Wasser M; Lai L; Tam WL; Lim TKH; Wan WK; Loh T; Leow WQ; Pang YH; Chan CY; Lee SY; Cheow PC; Toh HC; Ginhoux F; Iyer S; Kow AWC; Young Dan Y; Chung A; Bonney GK; Goh BKP; Albani S; Chow PKH; Zhai W; Chew V
    Nat Commun; 2021 Jan; 12(1):227. PubMed ID: 33431814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour-associated macrophages heterogeneity drives resistance to clinical therapy.
    Guo S; Chen X; Guo C; Wang W
    Expert Rev Mol Med; 2022 Apr; 24():e17. PubMed ID: 35400355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spatial biology of cancer evolution.
    Seferbekova Z; Lomakin A; Yates LR; Gerstung M
    Nat Rev Genet; 2023 May; 24(5):295-313. PubMed ID: 36494509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrating genetic and non-genetic determinants of cancer evolution by single-cell multi-omics.
    Nam AS; Chaligne R; Landau DA
    Nat Rev Genet; 2021 Jan; 22(1):3-18. PubMed ID: 32807900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Origin and evolution of animal multicellularity in the light of phylogenomics and cancer genetics.
    Jacques F; Baratchart E; Pienta KJ; Hammarlund EU
    Med Oncol; 2022 Aug; 39(11):160. PubMed ID: 35972622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear factor one transcription factors as epigenetic regulators in cancer.
    Fane M; Harris L; Smith AG; Piper M
    Int J Cancer; 2017 Jun; 140(12):2634-2641. PubMed ID: 28076901
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Saxena K; Subbalakshmi AR; Kulkarni P; Jolly MK
    J Biosci; 2022; 47():. PubMed ID: 36210746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hallmarks of transcriptional intratumour heterogeneity across a thousand tumours.
    Gavish A; Tyler M; Greenwald AC; Hoefflin R; Simkin D; Tschernichovsky R; Galili Darnell N; Somech E; Barbolin C; Antman T; Kovarsky D; Barrett T; Gonzalez Castro LN; Halder D; Chanoch-Myers R; Laffy J; Mints M; Wider A; Tal R; Spitzer A; Hara T; Raitses-Gurevich M; Stossel C; Golan T; Tirosh A; SuvĂ  ML; Puram SV; Tirosh I
    Nature; 2023 Jun; 618(7965):598-606. PubMed ID: 37258682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Epigenetic Perspective on Intra-Tumour Heterogeneity: Novel Insights and New Challenges from Multiple Fields.
    Beyes S; Bediaga NG; Zippo A
    Cancers (Basel); 2021 Oct; 13(19):. PubMed ID: 34638453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular principles of metastasis: a hallmark of cancer revisited.
    Fares J; Fares MY; Khachfe HH; Salhab HA; Fares Y
    Signal Transduct Target Ther; 2020 Mar; 5(1):28. PubMed ID: 32296047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour heterogeneity and resistance to cancer therapies.
    Dagogo-Jack I; Shaw AT
    Nat Rev Clin Oncol; 2018 Feb; 15(2):81-94. PubMed ID: 29115304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-cell omics traces the heterogeneity of prostate cancer cells and the tumor microenvironment.
    Yu X; Liu R; Gao W; Wang X; Zhang Y
    Cell Mol Biol Lett; 2023 May; 28(1):38. PubMed ID: 37161356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Practical Approach to Tumor Heterogeneity in Clinical Research and Diagnostics.
    Stanta G; Bonin S
    Pathobiology; 2018; 85(1-2):7-17. PubMed ID: 28750401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leveraging single-cell sequencing to unravel intratumour heterogeneity and tumour evolution in human cancers.
    Bowes AL; Tarabichi M; Pillay N; Van Loo P
    J Pathol; 2022 Jul; 257(4):466-478. PubMed ID: 35438189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.